Manchester Financial’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,000
Closed -$296K 104
2022
Q4
$296K Hold
10,000
0.08% 72
2022
Q3
$390K Sell
10,000
-1,439
-13% -$65.9K 0.11% 57
2022
Q2
$441K Hold
11,439
0.17% 54
2022
Q1
$554K Hold
11,439
0.2% 49
2021
Q4
$841K Hold
11,439
0.3% 43
2021
Q3
$1.04M Hold
11,439
0.4% 40
2021
Q2
$718K Hold
11,439
0.28% 43
2021
Q1
$310K Hold
11,439
0.14% 56
2020
Q4
$209K Sell
11,439
-2,100
-16% -$37.7K 0.13% 58
2020
Q3
$243K Sell
13,539
-42,082
-76% -$726K 0.18% 45
2020
Q2
$918K Sell
55,621
-2,000
-3% -$31.5K 0.75% 27
2020
Q1
$744K Sell
57,621
-6,000
-9% -$97.9K 0.55% 28
2019
Q4
$1.17M Hold
63,621
0.46% 26
2019
Q3
$1.12M Sell
63,621
-19,000
-23% -$325K 0.49% 25
2019
Q2
$1.38M Sell
82,621
-10,000
-11% -$182K 0.62% 24
2019
Q1
$1.7M Buy
92,621
+14,453
+18% +$277K 0.82% 22
2018
Q4
$1.55M Buy
+78,168
New +$1.46M 0.84% 22

Other funds holding ASTH

Manchester Financial's ASTH Position: Q1 2023 in Review

Manchester Financial sold out of Astrana Health (ASTH) in Q1 2023, closing a stake of 10,000 shares — an estimated $296K sold.

Manchester Financial first reported a position in ASTH in Q4 2018 and held it in 17 quarters. The position peaked at $1.7M in Q1 2019. 133 funds tracked by Wall St. Rank hold ASTH as of Q1 2023.

  • Manchester Financial reported no remaining Astrana Health position as of Q1 2023 after selling out during the quarter.
  • Manchester Financial sold 10,000 Astrana Health shares in Q1 2023, an estimated $296K.
  • Manchester Financial first reported a position in Astrana Health in Q4 2018 and held it in 17 quarters.
  • Manchester Financial's Astrana Health position peaked at $1.7M in Q1 2019.
  • 133 funds tracked by Wall St. Rank held Astrana Health as of Q1 2023.

Based on Manchester Financial's 13F filing for Q1 2023, filed 19 Apr 2023.